Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Drug Import Task Force Meeting Rescheduled

This article was originally published in The Pink Sheet Daily

Executive Summary

The next HHS drug importation task force meeting has been rescheduled for April 5

You may also be interested in...



HHS Import Task Force Public Meeting Submissions Due April 6

FDA is extending by one week the deadline for requests to speak at the April 14 public meeting of the HHS drug importation task force

HHS Import Task Force Public Meeting Submissions Due April 6

FDA is extending by one week the deadline for requests to speak at the April 14 public meeting of the HHS drug importation task force

FDA Website Should List Internet Pharmacies Approved To Import, AARP Tells Task Force

A more secure reimportation regime is needed to protect consumers who are already purchasing drugs from other countries, AARP's Certner says at first HHS drug import task force meeting. The agency also needs resources to inspect foreign plants, he says.

Topics

UsernamePublicRestriction

Register

ID1130879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel